Skip to main content
. Author manuscript; available in PMC: 2020 Aug 13.
Published in final edited form as: Clin Transplant. 2019 Nov 4;33(12):e13738. doi: 10.1111/ctr.13738

TABLE 1.

Patient characteristics of kidney transplant recipients with primary glomerular disease as the cause of ESRD

IgA
(N = 306)
FSGS
(N = 298)
MN
(N = 81)
LN
(N = 177)
P-value
Age (y), mean 42.8 44.9 50.5 42.8 <.005
Sex, N (%) 212 (69) 184 (62) 55 (68) 38 (22) <.05
Male
Race, N (%) 259 (84) 233 (78) 71 (88) 140 (79) .07
Caucasian
BMI (kg/m2), mean 27.4 27.6 27.0 25.1 .05
Duration of disease prior to transplant (y), mean 7.1 7.6 7.5 8.3 .03
Dialysis duration prior to transplant (y), mean 1.2 2.0 1.7 2.4 <.005
Prior transplant, % 17 22 26 25 .15
Peak PRA, % 5.9 10.2 15.3 18.3 .005
HLA mismatch
 Mismatch >2, % 79 83 75 72
 HLA A, % 75 78 65 65 .005
 HLA B, % 79 83 74 70 .006
 HLA DR, % 69 72 72 64 .41
Donor type
 Deceased, % 41 65 61 57 .005
 Age (y), mean 41.5 41.7 40.2 40.1 .58
 Male, % 48 57 52 50 .15
 Caucasian, % 94 93 93 91 .53
Cold ischemia time (h), mean 16 22 20 29 .46
Delayed graft function, % 10 21 14 17 .01
Maintenance IS
 Prednisone, % 100 100 100 100 NA
 Calcineurin inhibitor, % 94 87 91 94 .01
 Mycophenolate, % 89 89 85 89 .81

Abbreviations: FSGS, focal segmental glomerulosclerosis; IgA, IgA nephropathy; LN, lupus nephritis; MN, membranous nephropathy.